Keller Monica, Weis Joachim, Schumacher Andrea, Griessmeier Barbara
Psychosoziale Nachsorgeeinrichtung, Chirurgische Univ.-Klinik, Im Neuenheimer Feld 155, 69120 Heidelberg, Germany.
Crit Rev Oncol Hematol. 2003 Jan;45(1):109-17. doi: 10.1016/s1040-8428(02)00021-5.
The paper provides an overview on the 11th scientific conference of the European Society for Psycho-Oncology (ESPO), which took place in June 2001, at Heidelberg, Germany. The main topics discussed during the conference were: (1) the state of the art of research on the effects of psychological interventions in cancer patients; (2) psychosocial aspects in the new field of cancer genetics; (3) recent developments in Quality of Life research; (4) Psycho-Oncology from an European perspective; and (5) children and cancer. The conference gave an impressive picture of the many achievements Psycho-Oncology in Europe has accomplished during the last years, in the clinical and scientific domain. With recent biomedical innovations Psycho-Oncology is facing new challenges. Despite these achievements limitations have become apparent. Identifying these limitations, future aims can be outlined. Among these, there is the need for methodological refinement, as well as for proof of clinical relevance of research results, in order to narrow the gap between research and practice.
本文概述了于2001年6月在德国海德堡举行的欧洲心理肿瘤学会（ESPO）第11届科学会议。会议期间讨论的主要主题有：（1）癌症患者心理干预效果的研究现状；（2）癌症遗传学新领域中的社会心理方面；（3）生活质量研究的最新进展；（4）欧洲视角下的心理肿瘤学；以及（5）儿童与癌症。此次会议展示了欧洲心理肿瘤学在过去几年临床和科学领域所取得的众多成就，令人印象深刻。随着近期生物医学的创新，心理肿瘤学正面临新的挑战。尽管取得了这些成就，但局限性也已显现。明确这些局限性后，便可勾勒出未来的目标。其中包括需要完善方法，以及证明研究结果的临床相关性，以缩小研究与实践之间的差距。
